ATE253366T1 - Verwendung von 7-apha-methyl-17-alpha-ethynyl- estrane derivaten zur behandlung von atherosclerose - Google Patents
Verwendung von 7-apha-methyl-17-alpha-ethynyl- estrane derivaten zur behandlung von atheroscleroseInfo
- Publication number
- ATE253366T1 ATE253366T1 AT98912450T AT98912450T ATE253366T1 AT E253366 T1 ATE253366 T1 AT E253366T1 AT 98912450 T AT98912450 T AT 98912450T AT 98912450 T AT98912450 T AT 98912450T AT E253366 T1 ATE253366 T1 AT E253366T1
- Authority
- AT
- Austria
- Prior art keywords
- apha
- ethynyl
- atherosclerosis
- alpha
- methyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97200646 | 1997-03-05 | ||
| PCT/EP1998/001293 WO1998039012A1 (en) | 1997-03-05 | 1998-03-03 | USE OF A 7α-METHYL-17α-ETHYNYL-ESTRANE DERIVATIVE FOR THE TREATMENT OF ATHEROSCLEROSIS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE253366T1 true ATE253366T1 (de) | 2003-11-15 |
Family
ID=8228079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98912450T ATE253366T1 (de) | 1997-03-05 | 1998-03-03 | Verwendung von 7-apha-methyl-17-alpha-ethynyl- estrane derivaten zur behandlung von atherosclerose |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0994713B1 (de) |
| JP (1) | JP2001515478A (de) |
| KR (1) | KR100556558B1 (de) |
| CN (1) | CN1159014C (de) |
| AR (1) | AR015371A1 (de) |
| AT (1) | ATE253366T1 (de) |
| AU (1) | AU733758B2 (de) |
| BR (1) | BR9808194A (de) |
| CA (1) | CA2283418A1 (de) |
| DE (1) | DE69819503T2 (de) |
| DK (1) | DK0994713T3 (de) |
| ES (1) | ES2210731T3 (de) |
| HK (1) | HK1025510A1 (de) |
| HU (1) | HUP0001499A3 (de) |
| IL (1) | IL123422A (de) |
| NO (1) | NO994305L (de) |
| PL (1) | PL335904A1 (de) |
| TR (1) | TR199902510T2 (de) |
| TW (1) | TW448049B (de) |
| WO (1) | WO1998039012A1 (de) |
| ZA (1) | ZA981731B (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19834931A1 (de) * | 1998-07-28 | 2000-02-24 | Jenapharm Gmbh | Verwendung von biogenen Estrogenen zur Hormonsubstitutionstherapie |
| CN100432093C (zh) | 1998-10-16 | 2008-11-12 | 欧加农股份有限公司 | 包含（7α,17α)-17-羟基-7-甲基-19-去甲-17-孕-5（10）-烯-20-炔-3-酮的高纯度组合物 |
-
1998
- 1998-02-24 IL IL12342298A patent/IL123422A/xx not_active IP Right Cessation
- 1998-02-24 TW TW087102648A patent/TW448049B/zh not_active IP Right Cessation
- 1998-03-02 ZA ZA981731A patent/ZA981731B/xx unknown
- 1998-03-03 DE DE69819503T patent/DE69819503T2/de not_active Expired - Fee Related
- 1998-03-03 KR KR1019997008051A patent/KR100556558B1/ko not_active IP Right Cessation
- 1998-03-03 PL PL98335904A patent/PL335904A1/xx unknown
- 1998-03-03 ES ES98912450T patent/ES2210731T3/es not_active Expired - Lifetime
- 1998-03-03 CA CA002283418A patent/CA2283418A1/en not_active Abandoned
- 1998-03-03 BR BR9808194-2A patent/BR9808194A/pt not_active Application Discontinuation
- 1998-03-03 JP JP53817498A patent/JP2001515478A/ja not_active Ceased
- 1998-03-03 HU HU0001499A patent/HUP0001499A3/hu unknown
- 1998-03-03 EP EP98912450A patent/EP0994713B1/de not_active Expired - Lifetime
- 1998-03-03 WO PCT/EP1998/001293 patent/WO1998039012A1/en active IP Right Grant
- 1998-03-03 AT AT98912450T patent/ATE253366T1/de not_active IP Right Cessation
- 1998-03-03 TR TR1999/02510T patent/TR199902510T2/xx unknown
- 1998-03-03 AU AU67284/98A patent/AU733758B2/en not_active Ceased
- 1998-03-03 CN CNB988042096A patent/CN1159014C/zh not_active Expired - Fee Related
- 1998-03-03 DK DK98912450T patent/DK0994713T3/da active
- 1998-03-04 AR ARP980100956A patent/AR015371A1/es not_active Application Discontinuation
-
1999
- 1999-09-03 NO NO994305A patent/NO994305L/no not_active Application Discontinuation
-
2000
- 2000-07-25 HK HK00104604A patent/HK1025510A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR100556558B1 (ko) | 2006-03-06 |
| TW448049B (en) | 2001-08-01 |
| ES2210731T3 (es) | 2004-07-01 |
| WO1998039012A1 (en) | 1998-09-11 |
| CN1252723A (zh) | 2000-05-10 |
| AU733758B2 (en) | 2001-05-24 |
| AU6728498A (en) | 1998-09-22 |
| DK0994713T3 (da) | 2004-03-08 |
| KR20000075966A (ko) | 2000-12-26 |
| DE69819503D1 (de) | 2003-12-11 |
| DE69819503T2 (de) | 2004-09-23 |
| IL123422A (en) | 2003-05-29 |
| AR015371A1 (es) | 2001-05-02 |
| HUP0001499A2 (hu) | 2000-11-28 |
| JP2001515478A (ja) | 2001-09-18 |
| NO994305D0 (no) | 1999-09-03 |
| CA2283418A1 (en) | 1998-09-11 |
| ZA981731B (en) | 1998-09-07 |
| IL123422A0 (en) | 1998-09-24 |
| TR199902510T2 (xx) | 2000-02-21 |
| NO994305L (no) | 1999-11-01 |
| PL335904A1 (en) | 2000-05-22 |
| BR9808194A (pt) | 2000-05-16 |
| HK1025510A1 (en) | 2000-11-17 |
| EP0994713A1 (de) | 2000-04-26 |
| HUP0001499A3 (en) | 2001-03-28 |
| CN1159014C (zh) | 2004-07-28 |
| EP0994713B1 (de) | 2003-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60019556D1 (de) | 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| DE69812681D1 (de) | Unsubstituierte polydiallylaminen zur behandlung von hypercholesterolemia | |
| DE69925306D1 (de) | Behandlung von kohlenwasserstoffgas | |
| ATE235481T1 (de) | Substituierte benzopyranderivate zur behandlung von entzündungen | |
| DE69836915D1 (de) | Mundpflegemittel zur behandlung von übelriechendem atem | |
| DE69724016D1 (de) | Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen erkrankungen der atemwege | |
| DE69827424D1 (de) | Vorrichtung zur gesteuerten thermischen Behandlung von Gewebe | |
| DE69835011D1 (de) | Unterschiedliche behandlung von prothesenteilen | |
| DE69806579D1 (de) | Anlage zur behandlung von nahrungsmitteln | |
| DE60019555D1 (de) | 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| ATE267180T1 (de) | Phosphorderivate zur behandlung von aids | |
| DE69943089D1 (de) | Methode zur behandlung von staphylokokkeninfektionen | |
| DE69807466D1 (de) | Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten | |
| ATE347372T1 (de) | Vakzine zur behandlung von mycosen | |
| ATE227278T1 (de) | Substituierte benzylamine-derivate und ihre verwendung zur behandlung von depression | |
| DE69939723D1 (de) | Verwendung von Intereferon Gamma zur Behandlung von Herzhypertrophie | |
| DE60001255T2 (de) | Zusammensetzung zur Behandlung von Polyesterfaser | |
| DE69834937D1 (de) | Antibiotika zur behandlung von magengeschwuren | |
| DE69837148D1 (de) | Chimäre proteine zur behandlung von diabetes | |
| ATE433323T1 (de) | Verwendung von erythropoietin zur behandlung von primärer hämochromatosen | |
| ATE235494T1 (de) | Imino-aza-anthracyclonderivate zur behandlung von amyloidosis | |
| ATE346840T1 (de) | Aminoalkylphenol-derivate zur behandlung von depression und gedächtnis-funktionsstörung | |
| DE69806062T2 (de) | Kombinationstherapie zur behandlung von aids | |
| ATE253366T1 (de) | Verwendung von 7-apha-methyl-17-alpha-ethynyl- estrane derivaten zur behandlung von atherosclerose | |
| DE59904564D1 (de) | Verwendung von acetylcholinesterase-inhibitoren zur behandlung von delirien |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |